(Press-News.org) Tendons are the body's marionette strings, connecting bones to muscles that raise an eyebrow or propel us into a full run.
That is, until an unusually forceful or awkward pull on the strings leaves us with a sprain, strain or tear. Surgeons attempt to repair over 300,000 of these injuries every year, and doctors visits for sore tendons run into the millions.
Using a combination of nanoscience and biomedical and civil engineering to explore tendon structure from atoms on up, researchers have unraveled part of the mystery behind why we have problems with our tendons.
A new study led by scientists at Case Western Reserve University examines single threads of these essential connectors and found the weakest links – potential targets for imaging techniques to detect problems before a tendon fails and for drugs to increase flexibility and heal damage. Their work is published in the September issue of Biophysical Journal.
The threads are fibrils of collagen, a tougher form of the soft tissue implanted in models' pouty lips.
"The fibrils are about five times stronger and can strain about five times farther than a tendon," said Steven Eppell, a professor of biomedical engineering and senior author of the study.
"About 80 to 90 percent of a tendon is collagen but mechanical properties like strength are probably controlled by the other stuff."
The other stuff is a cement that holds the bundles of fibrils together; it's made of molecules called proteoglycans. This cement or the interface between collagen fibrils and proteoglycans, is most likely the weakest link in the system, the researchers say.
The scientists suspected that's the case but direct testing of cement, which is more complex and less available than fibrils, was difficult. So, they decided to test the strength of just the collagen fibrils and then compare this with the strength of whole tendons.
To test the tensile strength of fibrils, which have a diameter 100 times smaller than the diameter of a human hair, Eppell's team used what is essentially a structural testing lab on a microchip. This allowed them to measure how far fibrils stretch and the pressures they withstand before breaking.
"It's the equivalent of what civil engineers use to test a steel beam under 100,000 pounds of pressure, shrunk to the micro level," said co-author Roberto Ballarini, a professor of civil engineering formerly at Case Western Reserve and now chairman of civil engineering at the University of Minnesota. Ballarini is one of the inventors of the device to test the fibrils' strength.
In the first tests of their kind, the scientists glued one end of fibrils taken from a sea cucumber to a stationary base and the other end to a movable pad. When pulled apart, the fibrils stretched up to 100 percent of their resting length before breaking. A tendon stretches only 10 to 20 percent before breaking.
The new technology, developed by Zhilei Shen during her Ph.D. dissertation work, allowed her to keep the fibrils hydrated in saline to mimic their condition in the body. Earlier testing on dehydrated fibrils and tendons gave her different results.
The investigators believe water actually toughens fibrils and tendons as a whole. Since the proteoglycans in the cement largely control the degree of hydration around the fibrils, the team suspects they may be useful targets when designing drugs to control tendon strength.
In collaborations with nanoscientists at Yeshiva University and multi-scale modeling experts at MIT, the researchers took the lead in applying for funding to continue their work.
Their next steps include more detailed testing of bundles of fibrils and whole tendons as well as computer modeling that connects behavior of individual atoms and their bonds to molecular behavior and finally to mechanics of simulated fibrils and tendons. The models will be tested against experimental data collected here in the biomedical engineering department at Case Western Reserve.
Although the work focuses on tendons, the investigation will also provide insight into the workings of collagen in ligaments, skin and even mineralized collagen in bone.
INFORMATION:
The National Institutes of Health and the National Science Foundation funded the research
The Achilles' heel of tendons
2010-09-22
ELSE PRESS RELEASES FROM THIS DATE:
Stroke gene discovered
2010-09-22
A Dutch-German medical research team led by Harald Schmidt from Maastricht University, Netherlands, and Christoph Kleinschnitz, University of Würzburg, Germany, has discovered that an enzyme is responsible for the death of nerve cells after a stroke. The enzyme NOX4 produces hydrogen peroxide, a caustic molecule also used in bleaching agents. Inhibition of NOX4 by an experimental new drug in mice with stroke dramatically reduces brain damage and preserves brain functions, even when given hours after the stroke. These findings will be published next week in the online, open ...
CRP genetic variants crucial in interpreting inflammatory disease activity
2010-09-22
CRP is commonly used as a serum marker for inflammation or infection, but the genetic effects of CRP variants on acute-phase serum CRP concentrations in patients with rheumatoid arthritis may be large enough to have a clinically relevant impact on the assessment of inflammatory disease activity, which in turn may influence therapeutic decision making. Furthermore, failure to take into account the potential for genetic effects may result in the inappropriate reassurance or under-treatment of patients simply because they carry low-CRP associated genetic variants. These are ...
Community health workers can effectively manage children with malaria and pneumonia
2010-09-22
Community Health Workers can safely and effectively provide integrated management of pneumonia and malaria to communities by dispensing amoxicillin to children with non-severe pneumonia and artemether-lumefantrine to children with malaria (after using rapid diagnostic tests). Furthermore, these activities result in a significant increase in the proportion of appropriately-timed antibiotic treatment for non-severe pneumonia and in a significant decrease in inappropriate use of antimalarials. These are the results from a study by Kojo Yeboah-Antwi from the Boston School ...
Too many systematic reviews?
2010-09-22
There are now 75 clinical trials and 11 systematic reviews of trials published every day, with no signs this pace is slowing. How will we ever cope?, ask Hilda Bastian, Paul Glasziou, and Sir Iain Chalmers in this week's PLoS Medicine, who also decry the continued poor quality of many of these studies.
Analysing the history and growth of reviews of evidence, the authors recommend that we must now reduce unnecessary trials and prioritise truly systematic review of the literature, so that the needs of patients, clinicians, and policymakers are met. "Streamlining and innovation ...
Asian efforts in AIDS vaccine development step up
2010-09-22
Regional efforts towards an AIDS vaccine must be strengthened and harmonized, says a new article in this week's PLoS Medicine Magazine. Yiming Shao from the National Center for AIDS/STD Control and Prevention in Beijing, China and colleagues from a range of Asian and international agencies announce the formation of AVAN—the AIDS Vaccine for Asia Network—that aims to strengthen its regional efforts in finding an AIDS vaccine.
The authors say that AVAN has been set up to help facilitate the development of a regional AIDS vaccine strategy that will: accelerate research ...
Self-management counseling for patients with heart failure does not improve outcomes
2010-09-22
Patients with mild to moderate heart failure who received educational materials and self-management counseling in an attempt to improve adherence to medical advice did not have a reduced rate of death or hospitalization compared to patients who received educational materials alone, according to a study in the September 22/29 issue of JAMA.
There have been advances in the development of effective therapies for heart failure, but challenges remain in the delivery of these therapies to patients. "Patient nonadherence to heart failure drugs ranges from 30 percent to 60 percent ...
Shorter biological marker length in aplastic anemia patients linked to higher relapse, death rates
2010-09-22
Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.
Severe aplastic anemia is characterized by life-threatening cytopenias (blood cell count below normal), but this condition can be treated by bone ...
Risk of infection after ultrasound-guided procedures is low, study suggests
2010-09-22
The incidence of serious infection after common ultrasound-guided procedures, such as biopsy, fine-needle aspiration (a form of biopsy) and thoracentesis (procedure involving needle drainage of the chest cavity) is low, according to a study in the October issue of the American Journal of Roentgenology (www.ajronline.org). Ultrasound imaging, also called ultrasound scanning or sonography, involves exposing part of the body to high-frequency sound waves to produce pictures of the inside of the body.
"Ultrasound-guided procedures are safe, effective and accurate in that ...
Adverse cardiac events are rare after a negative cardiac CTA exam, study suggests
2010-09-22
Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology (www.ajronline.org). Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.
Earlier discharge of patients with low-to-moderate risk chest pain after ...
Rethinking how hospitals react when a patient's health deteriorates
2010-09-22
The growing use of rapid response teams dispatched by hospitals to evaluate patients whose conditions have suddenly deteriorated may be masking systemic problems in how hospitals care for their sickest patients, says a prominent Johns Hopkins patient safety expert.
In a commentary published in the Sept. 22 issue of the Journal of the American Medical Association, Peter Pronovost, M.D., Ph.D., a professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine, and co-author Eugene Litvak, Ph.D., president of the Institute for Healthcare ...